1.
Zh Nevrol Psikhiatr Im S S Korsakova
; 124(4): 36-42, 2024.
Artigo
em Russo
| MEDLINE
| ID: mdl-38676675
RESUMO
The review discusses aspects of the use of atypical antipsychotics in the treatment of depression in affective disorders and schizophrenia using the model of aripiprazole, a partial agonist of dopamine receptors. According to numerous studies, aripiprazole is the drug of choice for augmentative therapy of major depressive disorder, as well as for relieving and long-term maintenance monotherapy and combination therapy of various affective episodes of bipolar affective disorder and depression in schizophrenia.